Clinical relevance of plasma endostatin levels in patients with acute myeloid leukemia or myelodysplastic syndrome.

被引：0
|
作者：
Lai, R [1 ]
Estey, E [1 ]
Yu, S [1 ]
Kantarjian, H [1 ]
Gidel, C [1 ]
Beran, M [1 ]
Manshouri, T [1 ]
Quackenbush, R [1 ]
Keating, M [1 ]
Albitar, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
455
引用
收藏
页码：106A / 106A
页数：1
相关论文
共 50 条
  • [21] Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome
    S Verstovsek
    H Kantarjian
    E Estey
    A Aguayo
    FJ Giles
    T Manshouri
    C Koller
    Z Estrov
    E Freireich
    M Keating
    M Albitar
    Leukemia, 2001, 15 : 1165 - 1170
  • [22] NUMBER OF TP53 ABNORMALITIES AND THEIR CLINICAL RELEVANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Montalban-Bravo, G.
    Benton, C.
    Kadia, T.
    Ravandi, F.
    Cortes, J.
    Daver, N.
    Takahashi, K.
    DiNardo, C.
    Jabbour, E.
    Borthakur, G.
    Pemmaraju, N.
    Konopleva, M.
    Alfonso, A.
    Pierce, S.
    Bueso-Ramos, C.
    Kornblau, S.
    Patel, K.
    Kantarjian, H.
    Andreeff, M.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 48 - 48
  • [23] Landscape of TP53 Abnormalities and Their Clinical Relevance in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Montalban-Bravo, Guillermo
    Benton, Christopher B.
    Kanagal-Shamanna, Rashmi
    Sasaki, Koji
    Assi, Rita
    Kadia, Tapan M.
    Ravandi, Farhad
    Ganan-Gomez, Irene
    Cortes, Jorge E.
    Daver, Naval G.
    Takahashi, Koichi
    DiNardo, Courtney D.
    Jabbour, Elias J.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina Y.
    Pierce, Sherry A.
    Bueso-Ramos, Carlos E.
    Kornblau, Steven M.
    Patel, Keyur
    Colla, Simona
    Kantarjian, Hagop M.
    Andreeff, Michael
    Garcia-Manero, Guillermo
    BLOOD, 2018, 132
  • [24] Assessment of Plasma Endostatin Levels in Patients with Acute Myeloblastic and Lymphoblastic Leukemia
    Dagdas, Simten
    Ozet, Gulsum
    Yilmaz, Mesude
    Albayrak, Murat
    Ceran, Funda
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (04): : 210 - 216
  • [25] Clinical relevance of peripheral blood blasts in the myelodysplastic syndrome.
    Amin, HM
    Estey, EH
    Giles, FJ
    Pierce, SA
    Kantarjian, HM
    O'Brien, SM
    Albitar, M
    BLOOD, 2003, 102 (11) : 424A - 424A
  • [26] Familial myelodysplastic syndrome/acute myeloid leukemia
    Churpek, Jane E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (04) : 287 - 289
  • [27] Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome
    Albitar, M
    ACTA HAEMATOLOGICA, 2001, 106 (04) : 170 - 176
  • [28] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [29] MATRIX METALLOPROTEINASE-9 AND-2 LEVELS IN BONE MARROW PLASMA OF PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA
    Lesnichenko, I.
    Gritsaev, S.
    Kostroma, I.
    LEUKEMIA RESEARCH, 2015, 39 : S76 - S76
  • [30] Treatment and clinical outcome of patients with secondary acute myeloid leukemia (myelodysplastic syndrome-related).
    Galanopoulos, AG
    Tsourveloudis, I
    Leivada, A
    Kefalou, P
    Belechri, M
    Michalis, E
    Marinakis, T
    Gortzolidis, G
    Zomas, A
    Skandalis, A
    Anagnostopoulos, NI
    BLOOD, 2003, 102 (11) : 328B - 329B
12345